Carcinogenesis Advance Access originally published online on February 4, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis, Vol. 25, No. 6, 1005-1010,
June 2004
Carcinogenesis vol.25 no.6 © Oxford University Press 2004; all rights reserved.
ARTICLE |
Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma
1 Department of Pediatrics, 2 Department of Urology, 3 Research Institute for Frontier Questions of Medicine and Biotechnology and 4 Institute of Pathology, Paracelsus Private Medical University Salzburg, Muellner Hauptstr. 48, A-5020 Salzburg, Austria
5 To whom correspondence should be addressed Email: b.kofler{at}lks.at
To elucidate the relationship between tumorgenesis and the mitochondrial energy metabolism in renal neoplasms, we studied three individual enzyme activities of the oxidative phosphorylation, two components of the Krebs cycle and the mitochondrial DNA content of renal carcinomas including 29 conventional, five papillary, two unclassified carcinomas with sarcomatoid features and one collecting duct carcinoma. A significant reduction of all mitochondrial enzyme activities including complex V, as well as of the mitochondrial DNA content was detected in 34 of 37 renal carcinoma tissues as compared with control kidney. Mitochondrial enzyme activities and mitochondrial DNA levels were not statistically different between the conventional, papillary and unclassified sarcomatoid type of renal carcinoma and did not correlate with tumour grade, metastasis, ploidy and proliferative activity as determined by Ki-67 staining. Taken together, our data indicate that a co-ordinated down-regulation of all components necessary for mitochondrial energy metabolism occurs in most renal carcinomas as an early event in carcinoma formation, which does not change with progression of the disease.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A.M. Hall, R.J. Unwin, M.G. Hanna, and M.R. Duchen Renal function and mitochondrial cytopathy (MC): more questions than answers? QJM, October 1, 2008; 101(10): 755 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xing, M. Chen, C. G. Wood, J. Lin, M. R. Spitz, J. Ma, C. I. Amos, P. G. Shields, N. L. Benowitz, J. Gu, et al. Mitochondrial DNA Content: Its Genetic Heritability and Association With Renal Cell Carcinoma J Natl Cancer Inst, August 6, 2008; 100(15): 1104 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hervouet, A. Cizkova, J. Demont, A. Vojtiskova, P. Pecina, N. L.W. Franssen-van Hal, J. Keijer, H. Simonnet, R. Ivanek, S. Kmoch, et al. HIF and reactive oxygen species regulate oxidative phosphorylation in cancer Carcinogenesis, August 1, 2008; 29(8): 1528 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Mayr, D. Meierhofer, F. Zimmermann, R. Feichtinger, C. Kogler, M. Ratschek, N. Schmeller, W. Sperl, and B. Kofler Loss of Complex I due to Mitochondrial DNA Mutations in Renal Oncocytoma Clin. Cancer Res., April 15, 2008; 14(8): 2270 - 2275. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guha, S. Srinivasan, G. Biswas, and N. G. Avadhani Activation of a Novel Calcineurin-mediated Insulin-like Growth Factor-1 Receptor Pathway, Altered Metabolism, and Tumor Cell Invasion in Cells Subjected to Mitochondrial Respiratory Stress J. Biol. Chem., May 11, 2007; 282(19): 14536 - 14546. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Santamaria, M. Martinez-Diez, I. Fabregat, and J. M. Cuezva Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase Carcinogenesis, May 1, 2006; 27(5): 925 - 935. [Abstract] [Full Text] [PDF] |
||||




